Oculus, Ruthigen dermatology news

Oculus said that it made modifications to its corporate governance following the IPO of its former subsidiary, Ruthigen. Oculus has appointed two independent directors to its board after two members resigned; eliminated the chairman position; elected Jerry McLaughlin as lead independent director; and issued new committee assignments for its board members. Oculus will also review its corporate governance policies annually and modify the company's written charters. Oculus could not be reached for details (see BioCentury, March 24). ...